Response to: Comment on “New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept”

Response to: Comment on “New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept”

Bibliographic Details
Main Authors: Mariana P. Miranda-Hernández, Carlos A. López-Morales, Francisco C. Perdomo-Abúndez, Rodolfo D. Salazar-Flores, Nancy D. Ramírez-Ibanez, Nestor O. Pérez, Aaron Molina-Pérez, Jorge Revilla-Beltri, Emilio Medina-Rivero, Luis F. Flores-Ortiz
Format: Article
Language:English
Published: Hindawi Limited 2018-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2018/6156024
id doaj-482154dc3c6941c0a2a0642085089ad7
record_format Article
spelling doaj-482154dc3c6941c0a2a0642085089ad72020-11-25T00:02:22ZengHindawi LimitedJournal of Immunology Research2314-88612314-71562018-01-01201810.1155/2018/61560246156024Response to: Comment on “New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept”Mariana P. Miranda-Hernández0Carlos A. López-Morales1Francisco C. Perdomo-Abúndez2Rodolfo D. Salazar-Flores3Nancy D. Ramírez-Ibanez4Nestor O. Pérez5Aaron Molina-Pérez6Jorge Revilla-Beltri7Emilio Medina-Rivero8Luis F. Flores-Ortiz9Unidad de Investigación y Desarrollo, Probiomed S.A. de C.V., Cruce de Carreteras Acatzingo-Zumpahuacán S/N, Colonia Los Shiperes, 52400 Tenancingo de Degollado, MEX, MexicoUnidad de Investigación y Desarrollo, Probiomed S.A. de C.V., Cruce de Carreteras Acatzingo-Zumpahuacán S/N, Colonia Los Shiperes, 52400 Tenancingo de Degollado, MEX, MexicoUnidad de Investigación y Desarrollo, Probiomed S.A. de C.V., Cruce de Carreteras Acatzingo-Zumpahuacán S/N, Colonia Los Shiperes, 52400 Tenancingo de Degollado, MEX, MexicoUnidad de Investigación y Desarrollo, Probiomed S.A. de C.V., Cruce de Carreteras Acatzingo-Zumpahuacán S/N, Colonia Los Shiperes, 52400 Tenancingo de Degollado, MEX, MexicoUnidad de Investigación y Desarrollo, Probiomed S.A. de C.V., Cruce de Carreteras Acatzingo-Zumpahuacán S/N, Colonia Los Shiperes, 52400 Tenancingo de Degollado, MEX, MexicoUnidad de Investigación y Desarrollo, Probiomed S.A. de C.V., Cruce de Carreteras Acatzingo-Zumpahuacán S/N, Colonia Los Shiperes, 52400 Tenancingo de Degollado, MEX, MexicoUnidad de Investigación y Desarrollo, Probiomed S.A. de C.V., Cruce de Carreteras Acatzingo-Zumpahuacán S/N, Colonia Los Shiperes, 52400 Tenancingo de Degollado, MEX, MexicoUnidad de Investigación y Desarrollo, Probiomed S.A. de C.V., Cruce de Carreteras Acatzingo-Zumpahuacán S/N, Colonia Los Shiperes, 52400 Tenancingo de Degollado, MEX, MexicoUnidad de Investigación y Desarrollo, Probiomed S.A. de C.V., Cruce de Carreteras Acatzingo-Zumpahuacán S/N, Colonia Los Shiperes, 52400 Tenancingo de Degollado, MEX, MexicoUnidad de Investigación y Desarrollo, Probiomed S.A. de C.V., Cruce de Carreteras Acatzingo-Zumpahuacán S/N, Colonia Los Shiperes, 52400 Tenancingo de Degollado, MEX, Mexicohttp://dx.doi.org/10.1155/2018/6156024
collection DOAJ
language English
format Article
sources DOAJ
author Mariana P. Miranda-Hernández
Carlos A. López-Morales
Francisco C. Perdomo-Abúndez
Rodolfo D. Salazar-Flores
Nancy D. Ramírez-Ibanez
Nestor O. Pérez
Aaron Molina-Pérez
Jorge Revilla-Beltri
Emilio Medina-Rivero
Luis F. Flores-Ortiz
spellingShingle Mariana P. Miranda-Hernández
Carlos A. López-Morales
Francisco C. Perdomo-Abúndez
Rodolfo D. Salazar-Flores
Nancy D. Ramírez-Ibanez
Nestor O. Pérez
Aaron Molina-Pérez
Jorge Revilla-Beltri
Emilio Medina-Rivero
Luis F. Flores-Ortiz
Response to: Comment on “New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept”
Journal of Immunology Research
author_facet Mariana P. Miranda-Hernández
Carlos A. López-Morales
Francisco C. Perdomo-Abúndez
Rodolfo D. Salazar-Flores
Nancy D. Ramírez-Ibanez
Nestor O. Pérez
Aaron Molina-Pérez
Jorge Revilla-Beltri
Emilio Medina-Rivero
Luis F. Flores-Ortiz
author_sort Mariana P. Miranda-Hernández
title Response to: Comment on “New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept”
title_short Response to: Comment on “New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept”
title_full Response to: Comment on “New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept”
title_fullStr Response to: Comment on “New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept”
title_full_unstemmed Response to: Comment on “New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept”
title_sort response to: comment on “new alternatives for autoimmune disease treatments: physicochemical and clinical comparability of biosimilar etanercept”
publisher Hindawi Limited
series Journal of Immunology Research
issn 2314-8861
2314-7156
publishDate 2018-01-01
url http://dx.doi.org/10.1155/2018/6156024
work_keys_str_mv AT marianapmirandahernandez responsetocommentonnewalternativesforautoimmunediseasetreatmentsphysicochemicalandclinicalcomparabilityofbiosimilaretanercept
AT carlosalopezmorales responsetocommentonnewalternativesforautoimmunediseasetreatmentsphysicochemicalandclinicalcomparabilityofbiosimilaretanercept
AT franciscocperdomoabundez responsetocommentonnewalternativesforautoimmunediseasetreatmentsphysicochemicalandclinicalcomparabilityofbiosimilaretanercept
AT rodolfodsalazarflores responsetocommentonnewalternativesforautoimmunediseasetreatmentsphysicochemicalandclinicalcomparabilityofbiosimilaretanercept
AT nancydramirezibanez responsetocommentonnewalternativesforautoimmunediseasetreatmentsphysicochemicalandclinicalcomparabilityofbiosimilaretanercept
AT nestoroperez responsetocommentonnewalternativesforautoimmunediseasetreatmentsphysicochemicalandclinicalcomparabilityofbiosimilaretanercept
AT aaronmolinaperez responsetocommentonnewalternativesforautoimmunediseasetreatmentsphysicochemicalandclinicalcomparabilityofbiosimilaretanercept
AT jorgerevillabeltri responsetocommentonnewalternativesforautoimmunediseasetreatmentsphysicochemicalandclinicalcomparabilityofbiosimilaretanercept
AT emiliomedinarivero responsetocommentonnewalternativesforautoimmunediseasetreatmentsphysicochemicalandclinicalcomparabilityofbiosimilaretanercept
AT luisffloresortiz responsetocommentonnewalternativesforautoimmunediseasetreatmentsphysicochemicalandclinicalcomparabilityofbiosimilaretanercept
_version_ 1725438062755840000

Similar Items